Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anthracycline-based antibody drug conjugates having high in vivo tolerability

Anthracycline-based antibody drug conjugates having high in vivo tolerability

US Patent 12121527 · Granted Oct 22, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human antibodies binding to ROR22025
Human antibodies binding to ROR22025
Method of producing an immunoligand/payload conjugate2024
Method of producing an immunoligand/payload conjugate2024
Anti-ROR1 antibodies2023
Anti-ROR1 antibodies2023
Binding protein drug conjugates comprising anthracycline derivatives2023
Binding protein drug conjugates comprising anthracycline derivatives2023
Human antibodies binding to ROR22022
Human antibodies binding to ROR22022
Method of producing an immunoligand/payload conjugate2022
Method of producing an immunoligand/payload conjugate2022